CoChat
Sign Up
Cited by 191

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

MicroRNAs and lipid metabolism

Aryal, Binod, Singh, Abhishek K., Rotllan, Noemi, Price, Nathan, Fernández-Hernando, Carlos·2017·Current Opinion in Lipidology
DOI 10.1097/mol.0000000000000420PMC PMC5667558
Open this paper in CoChat — free account

Abstract

Purpose of review: Work over the past decade has identified the important role of microRNAs (miRNAS) in regulating lipoprotein metabolism and associated disorders including metabolic syndrome, obesity, and atherosclerosis. This review summarizes the most recent findings in the field, highlighting the contribution of miRNAs in controlling LDL-cholesterol (LDL-C) and HDL-cholesterol (HDL-C) metabolism. Recent findings: A number of miRNAs have emerged as important regulators of lipid metabolism, including miR-122 and miR-33. Work over the past 2 years has identified additional functions of miR-33 including the regulation of macrophage activation and mitochondrial metabolism. Moreover, it has recently been shown that miR-33 regulates vascular homeostasis and cardiac adaptation in response to pressure overload. In addition to miR-33 and miR-122, recent GWAS have identified single-nucleotide polymorphisms in the proximity of miRNA genes associated with abnormal levels of circulating lipids in humans. Several of these miRNAs, such as miR-148a and miR-128-1, target important proteins that regulate cellular cholesterol metabolism, including the LDL receptor (LDLR) and the ATP-binding cassette A1 (ABCA1). Summary: MicroRNAs have emerged as critical regulators of cholesterol metabolism and promising therapeutic targets for treating cardiometabolic disorders including atherosclerosis. Here, we discuss the recent findings in the field, highlighting the novel mechanisms by which miR-33 controls lipid metabolism and atherogenesis, and the identification of novel miRNAs that regulate LDL metabolism. Finally, we summarize the recent findings that identified miR-33 as an important noncoding RNA that controls cardiovascular homeostasis independent of its role in regulating lipid metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mol.0000000000000420

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several miRNAs are known to directly interact with the 3'UTR of LDLR, including miR-148a, miR-130b, miR-301b, miR-128-1, miR-185, and miR-27a/b.

    “More specifically, several miRNAs are known to directly interact with the 3’UTR of LDLR, such as miR-148a, miR-130b, miR-301b, miR-128-1, miR-185, and miR-27a/b47–49.”

    From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [48]

    The Introduction sections on miR-148a and miR-128-1 explicitly say that each directly targets the LDLR 3′UTR (page unavailable). Our copy does not establish that miR-130b, miR-301b, miR-185, or miR-27a/b directly target it; the HDL-C section instead discusses miR-185 in relation to SR-BI and miR-27a/b in relation to ABCA1. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. Glass, 2001, Atherosclerosis. the road ahead, Cell, 104, 503, 10.1016/S0092-8674(01)00238-0 · DOI
  2. Lusis, 2000, Atherosclerosis, Nature, 407, 233, 10.1038/35025203 · DOI
  3. Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
  4. Filipowicz, 2008, Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nature reviews, Genetics, 9, 102
  5. Olson, 2014, MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease, Sci Transl Med, 6, 10.1126/scitranslmed.3009008 · DOI
  6. Canfran-Duque, 2014, MicroRNAs and HDL life cycle, Cardiovasc Res, 103, 414, 10.1093/cvr/cvu140 · DOI
  7. Fernandez-Hernando, 2011, MicroRNAs in lipid metabolism, Curr Opin Lipidol, 22, 86, 10.1097/MOL.0b013e3283428d9d · DOI
  8. Horie, 2010, MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo, Proc Natl Acad Sci U S A, 107, 17321, 10.1073/pnas.1008499107 · DOI · Paper page
  9. Marquart, 2010, miR-33 links SREBP-2 induction to repression of sterol transporters, Proc Natl Acad Sci U S A, 107, 12228, 10.1073/pnas.1005191107 · DOI · Paper page
  10. Rayner, 2010, MiR-33 contributes to the regulation of cholesterol homeostasis, Science, 328, 1570, 10.1126/science.1189862 · DOI · Paper page
  11. Goedeke, 2015, MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels, Nat Med, 21, 1280, 10.1038/nm.3949 · DOI · Paper page
  12. Irani, 2016, MicroRNA-30c mimic mitigates hypercholesterolemia and atherosclerosis in mice, J Biol Chem, 291, 18397, 10.1074/jbc.M116.728451 · DOI
  13. Soh, 2013, MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion, Nat Med, 19, 892, 10.1038/nm.3200 · DOI
  14. Wagschal, 2015, Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis, Nat Med, 21, 1290, 10.1038/nm.3980 · DOI · Paper page
  15. Elmen, 2008, LNA-mediated microRNA silencing in nonhuman primates, Nature, 452, 896, 10.1038/nature06783 · DOI · Paper page
  16. Esau, 2006, miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, Cell Metab, 3, 87, 10.1016/j.cmet.2006.01.005 · DOI · Paper page
  17. Castoldi, 2011, The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice, J Clin Invest, 121, 1386, 10.1172/JCI44883 · DOI
  18. Hsu, 2012, Essential metabolic, anti-inflammatory, and antitumorigenic functions of miR-122 in liver, J Clin Invest, 122, 2871, 10.1172/JCI63539 · DOI
  19. Do, 2013, Common variants associated with plasma triglycerides and risk for coronary artery disease, Nat Genet, 45, 1345, 10.1038/ng.2795 · DOI · Paper page
  20. Global Lipids Genetics, 2013, Discovery and refinement of loci associated with lipid levels, Nat Genet, 45, 1274, 10.1038/ng.2797 · DOI
  21. Huan, 2015, Genome-wide identification of microRNA expression quantitative trait loci, Nature Commun, 6, 6601, 10.1038/ncomms7601 · DOI · Paper page
  22. Shi, 2015, miR-148a is associated with obesity and modulates adipocyte differentiation of mesenchymal stem cells through Wnt signaling, Sci Rep, 5, 9930, 10.1038/srep09930 · DOI
  23. Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat Genet, 22, 347, 10.1038/11914 · DOI · Paper page
  24. Kennedy, 2005, ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation, Cell Metab, 1, 121, 10.1016/j.cmet.2005.01.002 · DOI
  25. Chiang, 2009, Bile acids: regulation of synthesis, J Lipid Res, 50, 1955, 10.1194/jlr.R900010-JLR200 · DOI · Paper page
  26. Esteller, 2008, Physiology of bile secretion, World J Gastroenterol, 14, 5641, 10.3748/wjg.14.5641 · DOI
  27. Paulusma, 2008, ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity, Hepatology, 47, 268, 10.1002/hep.21950 · DOI
  28. Rottiers, 2012, MicroRNAs in metabolism and metabolic disorders. Nature reviews, Mol Cell Biol, 13, 239
  29. Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 13, 423, 10.1038/ncb2210 · DOI · Paper page
  30. Gelissen, 2006, ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I, Arterioscler Thromb Vasc Biol, 26, 534, 10.1161/01.ATV.0000200082.58536.e1 · DOI
  31. Rayner, 2011, Inhibition of miR-33a/b in nonhuman primates raises plasma HDL and lowers VLDL triglycerides, Nature, 478, 404, 10.1038/nature10486 · DOI · Paper page
  32. Rotllan, 2013, Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report, Arterioscler Thromb Vasc Biol, 33, 1973, 10.1161/ATVBAHA.113.301732 · DOI · Paper page
  33. Rottiers, 2013, Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR, Sci Transl Med, 5, 10.1126/scitranslmed.3006840 · DOI · Paper page
  34. Ouimet, 2016, Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism, Nat Immunol, 17, 677, 10.1038/ni.3434 · DOI
  35. Lai, 2016, MicroRNA-33 regulates the innate immune response via ATP binding cassette transporter-mediated remodeling of membrane microdomains, J Biol Chem, 291, 19651, 10.1074/jbc.M116.723056 · DOI · Paper page
  36. Dennis, 2010, A mouse macrophage lipidome, J Biol Chem, 285, 39976, 10.1074/jbc.M110.182915 · DOI
  37. Nishiga, 2017, MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol, Circ Res, 120, 835, 10.1161/CIRCRESAHA.116.309528 · DOI
  38. Huang, 2017, MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein, Cardiovasc Res, 10.1093/cvr/cvw257 · DOI
  39. Allen, 2014, Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33, Circ Res, 115, 10, 10.1161/CIRCRESAHA.115.303100 · DOI · Paper page
  40. Shimano, 1996, Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a, J Clin Invest, 98, 1575, 10.1172/JCI118951 · DOI
  41. Shimano, 1997, Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells, J Clin Invest, 99, 846, 10.1172/JCI119248 · DOI · Paper page
  42. Ramirez, 2011, MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1, Arterioscler Thromb Vasc Biol, 31, 2707, 10.1161/ATVBAHA.111.232066 · DOI · Paper page
  43. Ramirez, 2013, Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144, Circulation research, 112, 1592, 10.1161/CIRCRESAHA.112.300626 · DOI · Paper page
  44. Sun, 2012, MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7, FEBS Lett, 586, 1472, 10.1016/j.febslet.2012.03.068 · DOI
  45. Zhang, 2014, MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages, Atherosclerosis, 234, 54, 10.1016/j.atherosclerosis.2014.02.008 · DOI
  46. Meiler, 2015, MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis, Arteriosclerosis, thrombosis, and vascular biology, 35, 323, 10.1161/ATVBAHA.114.304878 · DOI
  47. Lv, 2014, MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1, Atherosclerosis, 236, 215, 10.1016/j.atherosclerosis.2014.07.005 · DOI
  48. Goedeke, 2015, miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice, Atherosclerosis, 243, 499, 10.1016/j.atherosclerosis.2015.09.033 · DOI · Paper page
  49. Vickers, 2013, MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia, Hepatology, 57, 533, 10.1002/hep.25846 · DOI
  50. Hu, 2012, MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells, Mol Cell Biol, 32, 5035, 10.1128/MCB.01002-12 · DOI
  51. Wang, 2013, MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition, Mol Cell Biol, 33, 1956, 10.1128/MCB.01580-12 · DOI
  52. Vickers, 2014, MicroRNA-223 coordinates cholesterol homeostasis, Proc Natl Acad Sci U S A, 111, 14518, 10.1073/pnas.1215767111 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Aryal, B., Singh, A. K., Rotllan, N., Price, N., & Fernández-Hernando, C.
Venue
Current Opinion in Lipidology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2017-06
Volume
28
Issue
3
Pages
273-280
ISSN
  • 0957-9672
  • 1473-6535
DOI
10.1097/mol.0000000000000420
PMC
PMC5667558
Cited by
191
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review